Total Funding
54
43
Total FundingSeries B raised
Growth Score
-3 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
47938
Third Pole develops products that generate and deliver electric nitric oxide for hospital, ambulatory, and home use.
David Zapol: Co-FounderPast Role: Third Pole, CEO- William Heiden: Chairman Of The BoardPast Role: Elixir Pharmaceuticals, CEO & President
About the Company
Third Pole core technology is an innovative, clean, tankless inhaled Nitric Oxide (NO) proven equivalent to marketed tank-gas in the lab. Nitric oxide saves hypoxic newborns, but it is only available in a limited number of countries, for those who can afford it, by physicians who have access to the product.
